Most women are evaluated for uterine cancer only after irregular bleeding occurs, such as with post menopausal women or bleeding between periods for younger women.
Clinical testing needs to be done. Based on very accurate lab only testing, there is great potential for this to become the 1st uterine cancer screening test
This test identified 91% of uterine cancers and had no false positives with the healthy controls. The data was published in the journal Cancer Research-see below
To conduct the test, a 2nd cervical sample can be obtained at the same time as a pap smear is performed, which will take less than a minute.
Similar to how sugars produced anywhere in the colon can be found at the rectum, sugars from uterine cells can be found at the cervix, which is the opening of the uterus.
Pap smears evaluate for cervical cancer, but not uterine cancer.
If uterine clinical testing for the altered sugar has anywhere near the accuracy as shown in the lab tests, then pap smears could be used to check for both cervical and uterine cancers.
A sample of mucus is needed to conduct this test. That said, a sample from the cervix may or may not contain mucus from the ovaries. Clinical research is needed.
Mucus from the pancreas can be obtained using a procedure called ERCP. On average ERCPs cost $5000+ and so screening of the pancreas is unlikely.